Michael Robert Harowicz

Conference American Journal of Respiratory and Critical Care Medicine · May 1, 2026 AbstractRationaleAccurate diagnosis of pulmonary nodules is essential for timely management and treatment of lung cancer. Both ... Full text Cite

Association of high proliferation marker Ki-67 expression with DCEMR imaging features of breast: A large scale evaluation

Conference Progress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2018 One of the methods widely used to measure the proliferative activity of cells in breast cancer patients is the immunohistochemical (IHC) measurement of the percentage of cells stained for nuclear antigen Ki-67. Use of Ki-67 expression as a prognostic marke ... Full text Cite

Deep learning-based features of breast MRI for prediction of occult invasive disease following a diagnosis of ductal carcinoma in situ: Preliminary data

Conference Progress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2018 Approximately 25% of patients with ductal carcinoma in situ (DCIS) diagnosed from core needle biopsy are subsequently upstaged to invasive cancer at surgical excision. Identifying patients with occult invasive disease is important as it changes treatment a ... Full text Cite

Breast cancer molecular subtype classification using deep features: Preliminary results

Conference Progress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2018 Radiogenomics is a field of investigation that attempts to examine the relationship between imaging characteris-tics of cancerous lesions and their genomic composition. This could offer a noninvasive alternative to establishing genomic characteristics of t ... Full text Cite

Can BI-RADS features on mammography be used as a surrogate for expensive genomic testing in breast cancer patients?

Conference Proceedings of SPIE the International Society for Optical Engineering · February 3, 2017 Cite

Can BI-RADS features on mammography be used as a surrogate for expensive genomic testing in breast cancer patients?

Conference Progress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2017 Medical oncologists increasingly rely on expensive genomic analysis to stratify patients for different treatment. The genomic markers are able to divide patients into groups that behave differently in terms of tumor presentation, likelihood of metastatic s ... Full text Cite